Your browser doesn't support javascript.
loading
Infection Prevalence in Adolescents and Adults With Acute Myeloid Leukemia Treated in an Indian Tertiary Care Center.
Jain, Hasmukh; Rengaraj, Karthik; Sharma, Vibhor; Bonda, Avinash; Chanana, Raajit; Thorat, Jayashree; Ronghe, Ashwini; Biswas, Sanjay; Nayak, Lingaraj; Tembhare, Prashant; Subramnian, Papagudi; Shetty, Dhanalaxmi; Patkar, Nikhil; Bagal, Bhausaheb; Sengar, Manju.
Afiliación
  • Jain H; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Rengaraj K; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Sharma V; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Bonda A; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Chanana R; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Thorat J; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Ronghe A; Medical Resident, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY.
  • Biswas S; Department of Microbiology, Tata Memorial Hospital, Mumbai, India.
  • Nayak L; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Tembhare P; Department of Hematopathology, Tata Memorial Hospital, Mumbai, India.
  • Subramnian P; Department of Hematopathology, Tata Memorial Hospital, Mumbai, India.
  • Shetty D; Department of Cancer Cytogenetics, Tata Memorial Hospital, Mumbai, India.
  • Patkar N; Department of Microbiology, Tata Memorial Hospital, Mumbai, India.
  • Bagal B; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
  • Sengar M; Department of Medical Oncology, Tata Memorial Hospital, affiliated to Homi Bhabha National Institute, Mumbai, India.
JCO Glob Oncol ; 6: 1684-1695, 2020 11.
Article en En | MEDLINE | ID: mdl-33156719
ABSTRACT

PURPOSE:

Infections remain a major challenge in the treatment of acute myeloid leukemia (AML). Induction-related mortality reported in the literature is approximately < 5% in clinical trials. However, the real-world scenario is different, especially in developing countries, given the high incidence of multidrug-resistant (MDR) organisms, high incidence of fungal pneumonia at baseline, and significant delay before initiation of chemotherapy. We aimed to look at contemporary infections and infection-related mortality and analyze the patterns of infections. MATERIALS AND

METHODS:

This retrospective study was conducted at a large tertiary care oncology center in India. Patients with newly diagnosed AML who were older than age 15 years, considered fit for intensive therapy, and treated in the general wards of the adult hematolymphoid unit from March 1, 2014, until December 31, 2015, were included.

RESULTS:

One hundred twenty-one patients were treated during the study period. The most common presenting complaint was fever (85%). The focus of infection at presentation was found in 63% of patients, with respiratory infection being the most common (47%). MDR organisms were isolated in 55% of patients during induction from various foci. Klebsiella pneumoniae was the most common blood culture isolate (42.9%). Fungal pneumonia was diagnosed in 55% of patients during induction despite antifungal prophylaxis. Treatment-related mortality was 10.7% in all phases, with an induction mortality rate of 7.4%. Complete remission was attained in 69% of patients. Of all patients who received induction chemotherapy, 74% completed all three consolidation cycles. The 121 patients were followed up for a median period of 53 months. Four-year event-free survival was 35.8%, and 4-year overall survival was 41.5%.

CONCLUSION:

Infections and infection-related mortality are major challenges during AML induction. Gram-negative MDR and fungal infections are particularly common in our region.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: Asia Idioma: En Revista: JCO Glob Oncol Año: 2020 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans País/Región como asunto: Asia Idioma: En Revista: JCO Glob Oncol Año: 2020 Tipo del documento: Article País de afiliación: India